SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Hana Biosciences (NASDAQ: HNAB), a biopharmaceutical company focused on advancing cancer care, will announce its 2006 third quarter results on Thursday, November 2nd, after the close of the financial markets.
